{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:12:53Z","timestamp":1781050373215,"version":"3.54.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s00417-025-06823-8","type":"journal-article","created":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T23:51:22Z","timestamp":1744588282000},"page":"2609-2617","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Anterior-Segment Optical Coherence Tomography Imaging of Patients Undergoing Supraciliary Glaucoma Drainage Device Implantation"],"prefix":"10.1007","volume":"263","author":[{"given":"Julien","family":"Torbey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Nassri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harsha L.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaweh","family":"Mansouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,14]]},"reference":[{"key":"6823_CR1","unstructured":"Weinreb RN, Ramulu P, Topouzis F, et al (2019) Glaucoma Surgery. Kugler Publications"},{"key":"6823_CR2","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1007\/s00417-013-2464-7","volume":"251","author":"K Mansouri","year":"2013","unstructured":"Mansouri K, Medeiros FA, Weinreb RN (2013) Global rates of glaucoma surgery. Graefe\u2019s Arch Clin Exp Ophthalmol 251:2609\u20132615. https:\/\/doi.org\/10.1007\/s00417-013-2464-7","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"key":"6823_CR3","doi-asserted-by":"publisher","first-page":"e0183142","DOI":"10.1371\/journal.pone.0183142","volume":"12","author":"C Lavia","year":"2017","unstructured":"Lavia C, Dallorto L, Maule M et al (2017) Minimally-invasive glaucoma surgeries (MIGS) for open angle glaucoma: A systematic review and meta-analysis. PLoS One 12:e0183142. https:\/\/doi.org\/10.1371\/journal.pone.0183142","journal-title":"PLoS One"},{"key":"6823_CR4","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/APO.0000000000000294","volume":"9","author":"K Gillmann","year":"2020","unstructured":"Gillmann K, Mansouri K (2020) Minimally Invasive Glaucoma Surgery: Where Is the Evidence? Asia Pac J Ophthalmol 9:203\u2013214. https:\/\/doi.org\/10.1097\/APO.0000000000000294","journal-title":"Asia Pac J Ophthalmol"},{"key":"6823_CR5","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ajo.2018.03.043","volume":"190","author":"NM Kerr","year":"2018","unstructured":"Kerr NM, Wang J, Perucho L, Barton K (2018) The Safety and Efficacy of Supraciliary Stenting Following Failed Glaucoma Surgery. Am J Ophthalmol 190:191\u2013196. https:\/\/doi.org\/10.1016\/j.ajo.2018.03.043","journal-title":"Am J Ophthalmol"},{"key":"6823_CR6","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ajo.2019.07.015","volume":"208","author":"G Reiss","year":"2019","unstructured":"Reiss G, Clifford B, Vold S et al (2019) Safety and Effectiveness of CyPass Supraciliary Micro-Stent in Primary Open-Angle Glaucoma: 5-Year Results from the COMPASS XT Study. Am J Ophthalmol 208:219\u2013225. https:\/\/doi.org\/10.1016\/j.ajo.2019.07.015","journal-title":"Am J Ophthalmol"},{"key":"6823_CR7","doi-asserted-by":"publisher","first-page":"99","DOI":"10.5005\/jp-journals-10078-1264","volume":"13","author":"IE Gabbay","year":"2019","unstructured":"Gabbay IE, Ruben S (2019) Cypass\u00ae micro-stent safety and efficacy at one year: Whahave we learned? J Curr Glaucoma Pract 13:99\u2013103. https:\/\/doi.org\/10.5005\/jp-journals-10078-1264","journal-title":"J Curr Glaucoma Pract"},{"key":"6823_CR8","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s10792-016-0282-8","volume":"37","author":"J Gonz\u00e1lez-Mart\u00edn-Moro","year":"2017","unstructured":"Gonz\u00e1lez-Mart\u00edn-Moro J, Contreras-Mart\u00edn I, Mu\u00f1oz-Negrete FJ et al (2017) Cyclodialysis: an update. Int Ophthalmol 37:441\u2013457","journal-title":"Int Ophthalmol"},{"key":"6823_CR9","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1089\/jop.2018.0036","volume":"34","author":"J Garc\u00eca-Feijoo","year":"2018","unstructured":"Garc\u00eca-Feijoo J, H\u00f6h H, Uzunov R, Dickerson JE (2018) Supraciliary Microstent in Refractory Open-Angle Glaucoma: Two-Year Outcomes from the DUETTE Trial. J Ocul Pharmacol Ther 34:538\u2013542. https:\/\/doi.org\/10.1089\/jop.2018.0036","journal-title":"J Ocul Pharmacol Ther"},{"key":"6823_CR10","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s12325-018-0666-4","volume":"35","author":"JS Myers","year":"2018","unstructured":"Myers JS, Masood I, Hornbeak DM et al (2018) Prospective Evaluation of Two iStent\u00ae Trabecular Stents, One iStent Supra\u00ae Suprachoroidal Stent, and Postoperative Prostaglandin in Refractory Glaucoma: 4-year Outcomes. Adv Ther 35:395\u2013407. https:\/\/doi.org\/10.1007\/s12325-018-0666-4","journal-title":"Adv Ther"},{"key":"6823_CR11","first-page":"141","volume":"6","author":"JP Gills","year":"1967","unstructured":"Gills JP, Paterson CA, Paterson ME (1967) Mode of action of cyclodialysis implants in man. Invest Ophthalmol 6:141\u2013144","journal-title":"Invest Ophthalmol"},{"key":"6823_CR12","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.ogla.2019.06.001","volume":"2","author":"P Denis","year":"2019","unstructured":"Denis P, Hirnei\u00df C, Reddy KP et al (2019) A First-in-Human Study of the Efficacy and Safety of MINIject in Patients with Medically Uncontrolled Open-Angle Glaucoma (STAR-I). Ophthalmol Glaucoma 2:290\u2013297. https:\/\/doi.org\/10.1016\/j.ogla.2019.06.001","journal-title":"Ophthalmol Glaucoma"},{"key":"6823_CR13","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1097\/IJG.0000000000001632","volume":"29","author":"J Garci\u00e1 Feijo\u00f3","year":"2020","unstructured":"Garci\u00e1 Feijo\u00f3 J, Denis P, Hirnei\u00df C et al (2020) A european study of the performance and safety of MINIject in patients with medically uncontrolled open-angle glaucoma (STAR-II). J Glaucoma 29:864\u2013871. https:\/\/doi.org\/10.1097\/IJG.0000000000001632","journal-title":"J Glaucoma"},{"key":"6823_CR14","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1136\/bjophthalmol-2020-316888","volume":"106","author":"P Denis","year":"2022","unstructured":"Denis P, Hirnei\u00df C, Durr GM et al (2022) Two-year outcomes of the MINIject drainage system for uncontrolled glaucoma from the STAR-I first-in-human trial. Br J Ophthalmol 106:65\u201370. https:\/\/doi.org\/10.1136\/bjophthalmol-2020-316888","journal-title":"Br J Ophthalmol"},{"key":"6823_CR15","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.ajo.2023.12.006","volume":"260","author":"HB Dick","year":"2023","unstructured":"Dick HB, Mackert MJ, Ahmed IIK et al (2023) Two-year performance and safety results of the MINIject supraciliary implant in patients with primary open-angle glaucoma: meta-analysis of the STAR-I, II, III Trials. Am J Ophthalmol 260:172\u201381. https:\/\/doi.org\/10.1016\/j.ajo.2023.12.006","journal-title":"Am J Ophthalmol"},{"key":"6823_CR16","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.survophthal.2011.04.004","volume":"56","author":"T Dada","year":"2011","unstructured":"Dada T, Gadia R, Sharma A et al (2011) Ultrasound Biomicroscopy in Glaucoma. Surv Ophthalmol 56:433\u2013450. https:\/\/doi.org\/10.1016\/j.survophthal.2011.04.004","journal-title":"Surv Ophthalmol"},{"key":"6823_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1755-3768.1992.tb04914.x","volume":"70","author":"CJ Pavlin","year":"1992","unstructured":"Pavlin CJ, Foster FS (1992) Ultrasound biomicroscopy in glaucoma. Acta Ophthalmol 70:7\u20139. https:\/\/doi.org\/10.1111\/j.1755-3768.1992.tb04914.x","journal-title":"Acta Ophthalmol"},{"key":"6823_CR18","doi-asserted-by":"publisher","first-page":"630","DOI":"10.4103\/0301-4738.169787","volume":"63","author":"J Maslin","year":"2015","unstructured":"Maslin J, Barkana Y, Dorairaj S (2015) Anterior segment imaging in glaucoma: An updated review. Indian J Ophthalmol 63:630\u2013640","journal-title":"Indian J Ophthalmol"},{"key":"6823_CR19","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.survophthal.2013.06.005","volume":"59","author":"R Sharma","year":"2014","unstructured":"Sharma R, Sharma A, Arora T et al (2014) Application of anterior segment optical coherence tomography in glaucoma. Surv Ophthalmol 59:311\u2013327. https:\/\/doi.org\/10.1016\/j.survophthal.2013.06.005","journal-title":"Surv Ophthalmol"},{"key":"6823_CR20","doi-asserted-by":"crossref","unstructured":"Saheb H, Ianchulev T, KA, Iqbal\u2018Ike\u2019 (2014) Optical coherence tomography of the suprachoroid after CyPass Micro-Stent implantation for the treatment of open-angle glaucoma. Br J Ophthalmol 98:1\u20132","DOI":"10.1136\/bjophthalmol-2012-302951"},{"key":"6823_CR21","doi-asserted-by":"publisher","first-page":"e617","DOI":"10.1111\/aos.14962","volume":"100","author":"JTC Kan","year":"2022","unstructured":"Kan JTC, Betzler BK, Lim SY, Ang BCH (2022) Anterior segment imaging in minimally invasive glaucoma surgery \u2013 A systematic review. Acta Ophthalmol 100:e617\u2013e634","journal-title":"Acta Ophthalmol"},{"key":"6823_CR22","doi-asserted-by":"publisher","first-page":"476801","DOI":"10.1155\/2012\/476801","volume":"2012","author":"S Salim","year":"2012","unstructured":"Salim S (2012) The Role of Anterior Segment Optical Coherence Tomography in Glaucoma. J Ophthalmol 2012:476801. https:\/\/doi.org\/10.1155\/2012\/476801","journal-title":"J Ophthalmol"},{"key":"6823_CR23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s00347-020-01106-5","volume":"118","author":"S Fili","year":"2021","unstructured":"Fili S, Seddig S, Vastardis I et al (2021) Explantation of the CyPass implant in a case series of patients with corneal decompensation. Ophthalmologe 118:42\u201349. https:\/\/doi.org\/10.1007\/s00347-020-01106-5","journal-title":"Ophthalmologe"},{"key":"6823_CR24","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ajo.2019.07.016","volume":"208","author":"JH Lass","year":"2019","unstructured":"Lass JH, Benetz BA, He J et al (2019) Corneal Endothelial Cell Loss and Morphometric Changes 5 Years after Phacoemulsification with or without CyPass Micro-Stent. Am J Ophthalmol 208:211\u2013218. https:\/\/doi.org\/10.1016\/j.ajo.2019.07.016","journal-title":"Am J Ophthalmol"},{"key":"6823_CR25","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s42490-020-00045-1","volume":"2","author":"I Grierson","year":"2020","unstructured":"Grierson I, Minckler D, Rippy MK et al (2020) A novel suprachoroidal microinvasive glaucoma implant: in vivo biocompatibility and biointegration. BMC Biomed Eng 2:10. https:\/\/doi.org\/10.1186\/s42490-020-00045-1","journal-title":"BMC Biomed Eng"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-06823-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-025-06823-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-06823-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T05:51:59Z","timestamp":1760075519000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-025-06823-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,14]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["6823"],"URL":"https:\/\/doi.org\/10.1007\/s00417-025-06823-8","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,14]]},"assertion":[{"value":"4 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr Kaweh Mansouri is a consultant for Santen, Abbvie, ImplanData, New World Medical, Th\u00e9a Pharma, iStar Medical, Alcon.Dr Rao HL is a consultant forSanten, Viatris, iSTAR, Abbvie.All other authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers\u2019 bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.This study was presented in part at the 10 th World Glaucoma Congress in Rome, Italy (June 28-July 1, 2023).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All procedures involving human participants were conducted in accordance with the 1964 Declaration of Helsinki and its subsequent amendments or comparable ethical standards. Ethical approval was provided by the Commission Cantonale d'\u00c9thique de la Recherche sur l'\u00catre Humain (CER-VD).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}